Fjoralba Kristo^1*, Flora Mazerolle^2*, Thibaud Alin^2*, Antoine Regnault^2*, Justin Ferdinandus, MD^3*, Karolin Behringer^3*, Janina Jablonski^3*, Peter Borchmann, MD³ and Ajibade Ashaye, MD, MS, MBA, MPH¹

¹Takeda Development Center Americas, Inc., Cambridge, MA
²Modus Outcomes, a THREAD company, Lyon, France
³German Hodgkin Study Group and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Maria Carmen Martinez Munoz, MD, PhD^1*, Irma Khvedelidze^2*, Mathilde Fekom^3*, Benedicte Deau Fischer, MD^4*, Amira Marouf^5*, Herve Ghesquieres, MD, PhD^6*, Luc-Matthieu Fornecker, MD, PhD^7*, Francesco Merli^8*, Piero Maria Stefani, MD^9*, Fulvio Massaro^10*, Barbara Botto^11*, A. Burhan Ferhanoglu, MD¹², Olga Meltem Akay^13*, Murat Ozbalak, MD^14*, Manuel Espeso De Haro^15*, Samuel Romero, MD^16*, Jaques-Emmanuel Galimard^17*, Bertram Glass, MD^18*, Ali Bazarbachi, MD, PhD¹⁹ and Anna Sureda Balari²⁰

¹Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain
²EBMT Paris Study Unit, Paris, France
³European Bone Marrow Transplantation Lymphoma Working Party, Paris, France
⁴Department of Hematology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris Cité, Paris, FRA
⁵INSERM UMR U1163—Imagine Institute, Paris, France
⁶Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
⁷Institut De Cancérologie Strasbourg Europe, Hematology Department, Strasbourg, France
⁸Hematology Department, AZIENDA USL-IRCCS DI REGGIO EMILIA, Reggio Emilia, Italy
⁹Struttura Complessa di Ematologia Dipartimento Strutturale di Medicina Interna, Presidio Ospedaliero di Treviso AULSS2 Marca Trevigiana, Treviso, Italy
¹⁰Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium
¹¹Division of Hematology, Città della Salute e della Scienza Hospital and University, Torino, Italy
¹²Koç University Medical Faculty, Istanbul, Turkey
¹³Koç University Medical Faculty, Istambul, Turkey
¹⁴Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey
¹⁵Hospital Regional Universitario de Málaga, MALAGA, Spain
¹⁶Hematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain
¹⁷EBMT Lymphoma Working Party, Paris, France
¹⁸Department of Hematology and Stem Cell Transplantation, Helios Klinikum Berlin-Buch, Berlin, Germany
¹⁹American University of Beirut Dept. of Medicine, Beirut, Lebanon
²⁰Instituto Catalán de Oncología - Hospital Duran i Reynals, Barcelona, Spain

Pamela B. Allen, MD¹, Latifa Bazzi, PhD^2*, Bin Zhang, MD, PhD^3*, Qing Chen, MD, PhD^4*, Liron Barnea Slonim, MD^4*, Hatice Savas, MD^5*, Ranjana H. Advani, MD⁶, Andrew M Evens, DO MBA MSc⁷, Barbara Pro, MD⁸, Reem Karmali, MD⁹, Eric Mou, MD^10*, Robert Eisner, DO¹¹, Robert Bayer, MD^11*, Leo I. Gordon, MD¹² and Jane N. Winter, MD^13*

¹Department of Hematology, Emory University School of Medicine, Decatur, GA
²Biostatistics, Northwestern, Chicago, IL
³Department of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL
⁴Pathology, Northwestern, Chicago, IL
⁵Radiology, Northwestern, Chicago, IL
⁶Department of Medicine, Division of Oncology and Hematology, Stanford University, Stanford, CA
⁷Rutgers Cancer Institute, New Brunswick, NJ
⁸Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
⁹Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
¹⁰Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
¹¹Feinberg School of Medicine, Northwestern University, Chicago, IL
¹²Northwestern University, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
¹³Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL

Antonio Vega Mateos, MD¹, Héctor Alejandro Vaquera Alfaro, MD², Ana Cristina Tejada Vasquez, MD², Yadith Karina Lopez-Garcia, MD¹, Gerardo Garcia-Salas, MD², Olga Cantu, MD^2*, Andres Gomez-De Leon, MD², David Gomez-Almaguer, MD², Luz Tarin-Arzaga, MD^2*, César Homero Gutierrez-Aguirre, MD^2* and Perla R. Colunga-Pedraza, MD²

¹Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico
²Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, NL, Mexico

Thomas M Kuczmarski, MD¹, Chaitra S. Ujjani, MD², Christina Poh, MD³, Edus H. Warren, MD, PhD¹, Stephen D. Smith, MD¹, Mazyar Shadman, MD, MPH³, Brian G. Till, MD⁴, Vikram Raghunathan, MD^1*, Yolanda D Tseng, MD^5*, Hongyan Du^3*, Jacquelin Vandermeer, BS^3*, Alyssa Kelly^3*, Heather Rasmussen^3*, Jenna M. Voutsinas, MPH^6*, Ajay K. Gopal, MD⁷ and Ryan C Lynch, MD³

¹Division of Hematology and Oncology, University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁵Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
⁶Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁷University of Washington, Seattle, WA

Thomas M Kuczmarski, MD¹, Chaitra S. Ujjani, MD², Christina Poh, MD³, Edus H. Warren, MD, PhD¹, Stephen D. Smith, MD^1,3, Mazyar Shadman, MD, MPH³, Brian G. Till, MD⁴, Vikram Raghunathan, MD^1*, Yolanda D Tseng, MD^5*, Hongyan Du^3*, Jacquelin Vandermeer, BS^3*, Alyssa Kelly^3*, Heather Rasmussen^3*, Jenna M. Voutsinas, MPH^6*, Ajay K. Gopal, MD⁷ and Ryan C Lynch, MD³

¹Division of Hematology and Oncology, University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutch Cancer Center; and Division of Oncology, University of Washington, Seattle, WA
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
⁵Department of Radiation Oncology, University of Washington and Fred Hutch Cancer Center, Seattle, WA
⁶Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁷University of Washington, Seattle, WA

Efrat Luttwak, MD¹, Swetha Kambhampati Thiruvengadam, MD², Esther Drill, DrPH^3*, Nivetha Ganesan, MPH^3*, Liron Hofstetter^4*, Ronit Gurion^5*, Shlomzion Aumann, MD^6,7*, Arnon Haran^8,9*, Mika Geva¹⁰, Marc Panossian^11,12*, Robert Stuver, MD¹, Paul A. Hamlin, MD¹, Ariela Noy, MD¹³, Alex F. Herrera, MD¹⁴ and Alison Moskowitz, MD¹

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²City of Hope National Medical Center, Yorba Linda, CA
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Faculty of Medicine, Tel Aviv University, Petah Tikva, Israel
⁵Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petach Tikva, Israel
⁶Department of Hematology, Hadassah Medical Center, Jerusalem, Israel
⁷Hebrew University, Jerusalem, Israel
⁸Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
⁹Department of Hematology, Hadassah Medical Center, Mevaseret Zion, Israel
¹⁰Sheba medical center, Ramat Gan, Israel
¹¹City of Hope, Durate, CA
¹²UCLA, Westwood, CA
¹³Memorial Sloan-Kettering Cancer Ctr., New York, NY
¹⁴City of Hope, Duarte, CA

Reid W. Merryman, MD¹, Justin Kline, MD², Robert A. Redd, MS^3*, Emma L. Welsh, BE^4*, Kathleen Pfaff, PhD^4*, Hannah Juhaie Lee^1*, Mikaela M. McDonough^5*, Inhye E. Ahn, MD¹, Jennifer R. Brown, MD, PhD⁶, Jennifer L. Crombie, MD¹, Matthew S. Davids, MD, MMSc¹, David C. Fisher, MD¹, Eric D. Jacobsen, MD⁷, Caron A. Jacobson, MD, MMSc¹, Austin I. Kim, MD⁵, Oreofe O. Odejide, MD¹, Erin M. Parry, MD, PhD¹, Christine E. Ryan, MD¹, Margaret A. Shipp, MD¹, Philippe Armand, MD, PhD¹, Scott J. Rodig, MD, PhD⁴, Jeremy S. Abramson, MD⁸ and Ann S. LaCasce, MD⁵

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Department of Medicine, Section of Hematology/Oncology, University of Chicago Medicine, Chicago, IL
³Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁴Department of Pathology, Brigham and Women's Hospital, Boston, MA
⁵Dana-Farber Cancer Institute, Boston, MA
⁶Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
⁷Dana Farber Cancer Institute, Boston, MA
⁸Massachusetts General Hospital Cancer Center, Boston, MA

Angelo Rizzolo, MD¹, Noah Ben-Ezra, MD^2*, Richard Liu, MD^2*, Matthew Salaciak, M.Sc.^3*, Peter Maliha, MD^4*, Stephan Probst, MD^2* and Nathalie A. Johnson, MD, PhD,⁵

¹Division of Hematology, Jewish General Hospital, Montreal, QC, Canada
²Division of Nuclear Medicine, Jewish General Hospital, Montreal, QC, Canada
³Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada
⁴Nuclear Medicine, Centre Hospitalier de l’Université de Montréal Centre de Recherche, Université de Montréal, Montreal, QC, Canada
⁵Jewish General Hospital, Montreal, QC, Canada

Cong Sun^1*, Xianhuo Wang, MD^2* and Huilai Zhang, MD³

¹Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
³Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China

Ariel Perez Perez, MD¹, Nayef Abdel-Razeq, MD^2*, Tiba Al Sagheer, PharmD^1*, George Nahas, DO¹, Jose Sandoval-Sus, MD³, Manny Alfonso, PharmD^3*, Carlos Silva, MD³, Syeda Saba Kareem, PharmD^4*, Katherine Tobon, PharmD, BS^4*, Allison C. Rosenthal, DO⁵, Stephen M. Ansell, MD, PhD⁶, Yuliya PL Linhares, MD¹, Muhamad Alhaj Moustafa, M.D., M.S.² and Hayder Saeed, MD⁴

¹Blood and Marrow Transplant Program, Miami Cancer Institute, Baptist Health South Florida, Miami, FL
²Division of Hematology, Mayo Clinic, Jacksonville, FL
³Moffitt Cancer Center at Memorial Healthcare System, Pembroke Pines, FL
⁴Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁵Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ
⁶Division of Hematology, Mayo Clinic, Rochester, MN

Hala Hassanain, MD^1,2*, Ethan A Burns, MD³, Sunil Mathur^3*, Darshil Choksi^4*, Cesar Giancarlo Gentille Sanchez, MD⁵, Chih-Chi Andrew Hu, PhD⁶, Mai Hanh^3*, Carrie Yuen, MD^3*, Shilpan S. Shah, MD^3*, Siddhartha Ganguly, MD⁷ and Sai Ravi Kiran Pingali, MD³

¹Internal Medicine, Department of Academic Medicine, Houston, TX
²Academy of Physician Scientists, Texas A&M, Houston
³Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX
⁴Dell Medical School, Austin, TX
⁵University of Arkansas for Medical Sciences, Little Rock, AR
⁶Houston Methodist Research Institute, Houston, TX
⁷Houston Methodist Hospital, Houston, TX

Yuqin Song, MD¹, Qingsong Yin, PhD^2*, Zhiming Li, PhD, MD³, Jingye Meng^4*, Yan Yan^5*, Mengli Zhou^5*, Wenyi Sun^5*, Kezhen Liu^5* and Jun Zhu, PhD¹

¹Peking University Cancer Hospital, Beijing, China
²Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, China
⁴Shenzhen Third People's Hospital, shenzhen, China
⁵Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd, Shanghai, China

Alex F. Herrera, MD¹, Swetha Kambhampati Thiruvengadam, MD¹, Michael A Spinner, MD², Christina Poh, MD³, Elizabeth H. Phillips^4*, Vincent Ribrag, MD⁵, Ming Jin Yan^6*, Tara Chen, PharmD⁶ and Julie M. Vose, MD, MBA⁷

¹City of Hope, Duarte, CA
²University of California San Francisco, San Francisco, CA
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Division of Cancer Sciences, University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom
⁵Institut Gustave Roussy, Villejuif, France
⁶Pfizer Inc, Bothell, WA
⁷Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE

Tae Min Kim, MD, PhD^1*, Katharine L. Lewis², Juan Pablo Alderuccio, MD³, Hun Ju Lee, MD⁴, Enrico Derenzini, MD, PhD^5*, Pier Luigi Zinzani, MD, PhD⁶, Marco Ladetto, MD⁷, Elizabeth H. Phillips^8*, Hervé Ghesquieres, MD, PhD^9*, François Lemonnier^10*, Franck Morschhauser¹¹, Ana Sureda Balari¹², Antonia Rodriguez Izquierdo^13*, Peter Borchmann, MD¹⁴, Matthew Weinstock^15*, Jakub Svoboda, MD¹⁶, Emma Dean^17*, Jelena Urosevic^17*, Stefanie Meyer^18*, Robert Chen^19*, Richard Olsson^20*, Kaitlyn Beyfuss^21* and Graham P. Collins²²

¹Seoul National University Hospital, Seoul, Korea, Republic of (South)
²Linear Clinical Research, Sir Charles Gairdner Hospital and the University of Western Australia, Perth, Western Australia, Australia
³Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵European Institute of Oncology, Milan, Italy
⁶University of Bologna, Istituto Di Ematologia, Bologna, Italy
⁷Ospedale Civile Ss. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
⁸University of Manchester, Christie NHS Foundation Trust and Division of Cancer Sciences, Manchester, United Kingdom
⁹Hospital Lyon Sud, Lyon, France
¹⁰Hopital Henri Mondor, Créteil, France
¹¹Centre Hospitalier Universitaire de Lille - Hopital Claude Huriez, Lille, France
¹²Instituto Catalán de Oncología - Hospital Duran i Reynals, Barcelona, Spain
¹³Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁴Universitätsklinikum Köln, Cologne, Germany
¹⁵Department of Hematology/Oncology, Beth Israel Deaconess Medical Center, Boston, MA
¹⁶Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
¹⁷Oncology R&D, AstraZeneca, Cambridge, United Kingdom
¹⁸Hematology R&D, AstraZeneca, Boston, MA
¹⁹Hematology R&D, AstraZeneca, Cambridge, United Kingdom
²⁰Hematology R&D, AstraZeneca, Mölndal, Sweden
²¹Hematology R&D, AstraZeneca, Mississauga, ON, Canada
²²Oxford Cancer and Haematology Centre, Oxford, United Kingdom

Hun Ju Lee, MD¹, Gregory Ravizzini, MD^1*, Eslam Aboismail, MD^1*, Jenna Wixom, BS^2*, Jared Henderson, PhD^1*, Luis E. Fayad, MD¹, Sairah Ahmed, MD³, Ranjit Nair, MD^3*, Jason R. Westin, MD^1,4, Swaminathan P Iyer, MD^5*, Chijioke Nze, MD, MPH³, Ajlan Al Zaki, MD, PhD⁶, Francisco Vega, MD, PhD⁷, Michael Wang, MD¹, Christopher R. Flowers, MD, MS³ and Luis Malpica, MD^3*

¹The University of Texas MD Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, HOUSTON, TX
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴The University of Texas M D Anderson Cancer Center, Houston, TX
⁵University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷MD Anderson Cancer Center , Houston, TX